Ovarian Cancer Biomarker Performance in Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Specimens

Establishing a cancer screening biomarker’s intended performance requires “phase III” specimens obtained in asymptomatic individuals before clinical diagnosis rather than “phase II” specimens obtained from symptomatic individuals at diagnosis. We used specimens from the Prostate, Lung, Colorectal, a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Cramer, Daniel W., Bast, Robert C., Berg, Christine D., Diamandis, Eleftherios P., Godwin, Andrew K., Hartge, Patricia, Lokshin, Anna E., Lu, Karen H., McIntosh, Martin W., Mor, Gil, Patriotis, Christos, Pinsky, Paul F., Thornquist, Mark D., Scholler, Nathalie, Skates, Steven J., Sluss, Patrick M., Srivastava, Sudhir, Ward, David C., Zhang, Zhen, Zhu, Claire S., Urban, Nicole
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3085251/
https://ncbi.nlm.nih.gov/pubmed/21372036
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-10-0195
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados